Loading…
NEXGEL, Inc. is projected to decline to $0.399 by 2027, a -6% move from its current price of $0.4232. NXGL is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.4059 | $0.423 | $0.4408 | -0.05% |
| Aug 6 | $0.3988 | $0.4228 | $0.4482 | -0.10% |
| Aug 7 | $0.3935 | $0.4226 | $0.4539 | -0.14% |
| Aug 8 | $0.389 | $0.4224 | $0.4587 | -0.19% |
| Aug 9 | $0.385 | $0.4222 | $0.463 | -0.24% |
| Aug 10 | $0.3814 | $0.422 | $0.4668 | -0.29% |
| Aug 11 | $0.3782 | $0.4218 | $0.4704 | -0.34% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.3782 | $0.4218 | $0.4704 | -0.34% |
| Week 2 | $0.3603 | $0.4203 | $0.4905 | -0.67% |
| Week 3 | $0.3468 | $0.4189 | $0.5061 | -1.01% |
| Week 4 | $0.3357 | $0.4175 | $0.5193 | -1.34% |
| Week 5 | $0.326 | $0.4161 | $0.5311 | -1.68% |
| Week 6 | $0.3175 | $0.4147 | $0.5417 | -2.01% |
| Week 7 | $0.3097 | $0.4133 | $0.5516 | -2.34% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs.
The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also develops NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business.
It serves its customers under Medagel, Kenkoderm and Silly George brand names. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019.
NEXGEL, Inc. was incorporated in 2009 and is based in Langhorne, Pennsylvania.
NEXGEL, Inc. is a healthcare stock that currently trades at $0.4404 per share. It has a market capitalization of $4.06M and is ranked 5091 by market capitalization. The price outlook is mixed when viewed across the 2026–2050 forecast, with a neutral tone in the near term and meaningful upside in the longer term.
The 2026 forecast shows an average price of $0.4404, with a min of $0.411 and a max of $0.5617, and an ROI of 0% in a neutral sentiment setting.
A major floor 34.1% below — a decisive break under it would weaken the trend.
Price is testing support right now (2.9% away) — a key level to hold.
The nearest ceiling, 44.4% above — a clean break opens room to run.
A major ceiling 78.6% above — clearing it would confirm fresh momentum.
Key NXGL support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NXGL market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.4366 | Sell | $0.433 | Sell |
| MA 10 | $0.4344 | Sell | $0.441 | Sell |
| MA 20 | $0.4641 | Sell | $0.4622 | Sell |
| MA 50 | $0.5227 | Sell | $0.5245 | Sell |
| MA 100 | $0.5899 | Sell | $0.6918 | Sell |
| MA 200 | $1.16 | Sell | $1.09 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 36.84 | Neutral |
| Stoch RSI (14) | 34.34 | Neutral |
| CCI (20) | -98.61 | Neutral |
| Williams %R (14) | -93.33 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | -9.78 | Sell |
| Bollinger %B (20,2) | 0.19 | Neutral |
| Stochastic %K (14) | 6.67 | Buy |
| TRIX (15) | -0.85 | Sell |
| Awesome (5,34) | -0.06 | Sell |
| Ultimate (7,14,28) | 45.08 | Neutral |
| Momentum (10) | -0.06 | Sell |
| Aroon Osc (25) | -56.00 | Sell |
| Hull MA (9) | 0.44 | Sell |
| ADX (14) | 17.95 | Neutral |
| ATR (14) | 0.02 | Info |
The 30-day technical picture is bearishly biased, with RSI14 at 40. The 50-day simple moving average is $0.5332 and the 200-day simple moving average is $1.21, indicating residual weakness versus longer-term trend lines. Near-term support sits at $0.411 and resistance at $0.611, suggesting a tight trading range around the current price.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.411 | $0.4232 | $0.5373 | 0% | Neutral | |
| $0.3036 | $0.399 | $0.5623 | -6% | Neutral | |
| $0.2789 | $0.3836 | $0.5701 | -9% | Neutral | |
| $0.2291 | $0.3272 | $0.5066 | -23% | Bearish | |
| $0.2777 | $0.4103 | $0.6569 | -3% | Neutral | |
| $0.3298 | $0.5026 | $0.8286 | +19% | Neutral | |
| $0.3073 | $0.4822 | $0.8159 | +14% | Neutral | |
| $0.3059 | $0.4935 | $0.8548 | +17% | Neutral | |
| $0.2864 | $0.4746 | $0.8397 | +12% | Neutral | |
| $0.2661 | $0.4525 | $0.8165 | +7% | Neutral | |
| $0.3212 | $0.6164 | $1.21 | +46% | Bullish | |
| $0.5456 | $1.21 | $2.67 | +186% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.411 | $0.4232 | $0.5002 | +0.00% |
| September 2026 | $0.327 | $0.3924 | $0.488 | -7.28% |
| October 2026 | $0.334 | $0.405 | $0.5117 | +3.20% |
| November 2026 | $0.3458 | $0.4229 | $0.5413 | +4.44% |
| December 2026 | $0.3367 | $0.4151 | $0.5373 | -1.86% |
Click any year to see its month-by-month NXGL forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The NXGL price prediction for 2026 points to an average of $0.4232 (low $0.411, high $0.5373) — a potential gain of 0% on today's $0.4232. Price action looks broadly range-bound.
In 2027, NXGL is projected to trade between $0.3036 and $0.5623, averaging $0.399 — a potential decline of -6% from today's $0.4232. That is -6% versus the projected 2026 average. A consolidation phase looks the most probable path here.
NEXGEL, Inc.'s 2028 outlook centres on $0.3836, within a $0.2789 to $0.5701 range. That is -4% versus the projected 2027 average. That marks a -9% change versus current levels. Price action looks broadly range-bound.
By 2029, NXGL could reach as high as $0.5066, with a base case around $0.3272 and support toward $0.2291 — roughly -23% from $0.4232. Expect choppier, lower action through this leg of the cycle.
Expect NXGL to range from $0.2777 to $0.6569 through 2030. The $0.4103 average target implies a -3% move from current prices. That is up +25% on the projected 2029 average. Price action looks broadly range-bound.
The NXGL price prediction for 2031 points to an average of $0.5026 (low $0.3298, high $0.8286) — a potential gain of +19% on today's $0.4232. A consolidation phase looks the most probable path here.
In 2032, NXGL is projected to trade between $0.3073 and $0.8159, averaging $0.4822 — a potential gain of +14% from today's $0.4232. That is -4% versus the projected 2031 average. Price action looks broadly range-bound.
NEXGEL, Inc.'s 2033 outlook centres on $0.4935, within a $0.3059 to $0.8548 range. That is up +2% on the projected 2032 average. That marks a +17% change versus current levels. A consolidation phase looks the most probable path here.
By 2034, NXGL could reach as high as $0.8397, with a base case around $0.4746 and support toward $0.2864 — roughly +12% from $0.4232. Price action looks broadly range-bound.
Expect NXGL to range from $0.2661 to $0.8165 through 2035. The $0.4525 average target implies a +7% move from current prices. That is -5% versus the projected 2034 average. A consolidation phase looks the most probable path here.
The NXGL price prediction for 2040 points to an average of $0.6164 (low $0.3212, high $1.21) — a potential gain of +46% on today's $0.4232. Momentum favours further upside here.
In 2050, NXGL is projected to trade between $0.5456 and $2.67, averaging $1.21 — a potential gain of +186% from today's $0.4232. That is up +97% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in NXGL today (≈ 2,362.94896 NXGL) could be worth
$2,864.88
+$1,864.88 (+186%) by 2050 · US Dollar
Based on the average projected NXGL price of $1.21 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NXGLwould be worth at today's price.
$1,000 invested in NXGL on Jul 31, 2025 (≈ 444.444444 NXGL) would be worth
$188.09
-$811.91 (-81.2%) today · 0.19× · US Dollar
Based on a NXGL entry price of $2.25 vs. today's $0.4232.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.439 | $964.01 | -3.6% |
| 1 month ago | $0.566 | $747.7 | -25.2% |
| 3 months ago | $0.581 | $728.4 | -27.2% |
| 6 months ago | $1.36 | $311.18 | -68.9% |
| 1 year ago | $2.25 | $188.09 | -81.2% |
| All time (4.6y) ago | $3.52 | $120.23 | -88.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NXGL forecast.
Our base-case forecast reaches $0.85 around 2050.
Implied market cap at $0.85: $7.84M
The multi-year forecast shows a mixed path with a neutral stance for 2026–2030 and a potential upside later. For 2030, the average price is $0.4258 with a min of $0.2797 and a max of $0.7013, and an ROI of -3.3% with neutral sentiment. The 2040 outlook improves to an average of $0.627, a min of $0.3043, a max of $1.28, and a 42.4% ROI with bullish sentiment.
By 2050, the forecast envisions an average price of $1.26, a min of $0.5649, a max of $2.89, and an ROI of 185% with bullish sentiment. Earlier years show a path of mixed results (for example 2029 with a max of $0.5168 and an ROI of -26.1%), illustrating the uncertainty around timing and magnitude of price moves.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $0.4258 with a min of $0.2797 and a max of $0.7013; ROI is -3.3% and sentiment is Neutral.
The forecast indicates a mixed path: neutral in 2026, with positive upside in years like 2031 (avg $0.5243, ROI 19.1%), 2040 (avg $0.627, ROI 42.4%), and 2050 (avg $1.26, ROI 185%), but negative ROI in some earlier years (e.g., 2027 -6.2%, 2028 -10.7%, 2029 -26.1%).
Yes. The long‑term max forecast reaches $2.89 by 2050, with an average around $1.26.
Current price is $0.4404 and market cap is $4.06M.
Bearish sentiment with RSI14 at 40. The 50-day SMA is $0.5332 and the 200-day SMA is $1.21, with support at $0.411 and resistance at $0.611. The 30-day range is $0.3265–$0.5941 and annualized volatility is 90%.
NEXGEL, Inc. Community Discussion
0Share your NEXGEL, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.